arginase greatly elevated asthma thought play role pathophysiology disease inhibitors phosphodiesterase NUMBER pde4 predominant pde macrophages elevate camp levels reduce inflammation proposed use treatment asthma chronic obstructive pulmonary disease camp inducer arginase tested hypothesis pde4 inhibitor enhance macrophage arginase induction key cytokines implicated asthma pulmonary diseases raw NUMBER cells stimulated transforming growth factor pde4 inhibitor rolipram increased arginase activity respectively rolipram effect combined synergistically enhanced arginase activity additional respectively increases arginase protein mrna levels mirrored increases arginase activity induction arginase ii mrna enhanced rolipram lesser extent arginase unlike effect raw NUMBER cells did increase arginase activity human alveolar macrophages healthy volunteers combining agents induce camp levels induced arginase activity human significantly level obtained agents conclusion agents elevate camp significantly enhance induction arginase cytokines consequences increased arginase expression evaluated pde inhibitors proposed treatment inflammatory disorders predominate il NUMBER tgf beta il NUMBER tgf beta NUMBER NUMBER fold il NUMBER tgf beta NUMBER NUMBER fold il NUMBER il NUMBER camp inducing il NUMBER tgf beta